GlassScriptPhysician profile
Thomas Higgins Gann
NPI 1538377205
$943.35
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $353 · 2021: $60.95 · 2022: $67.98 · 2023: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $105.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $351.78 | 2019-2023 | Briviact |
| Sk Life Science, INC. | $160.74 | 2020-2022 | |
| Neurelis, INC. | $90.67 | 2020-2023 | Valtoco |
| Grifols USA, LLC | $48.52 | 2019 | |
| Lundbeck LLC | $31.80 | 2019-2020 | |
| Tanabe Pharma America, INC. | $30.56 | 2019 | |
| Supernus Pharmaceuticals, INC. | $29.54 | 2019 | |
| Livanova USA, INC. | $27.43 | 2019 | |
| Amgen INC. | $24.96 | 2019-2020 | |
| Acorda Therapeutics, INC | $23.27 | 2019 | |
| Impel Pharmaceuticals INC. | $22.46 | 2022 | |
| Kedrion Biopharma INC. | $20.77 | 2019 | |
| Greenwich Biosciences, INC. | $18.94 | 2019 | |
| Medtronic, INC. | $16.58 | 2021 | |
| Genzyme Corporation | $16.35 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $16.06 | 2021 | |
| Grt US Holding, INC. | $12.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Gann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.